Geneva, Switzerland & Salisbury, UK – 28 September 2017 – FIND, a global non-profit dedicated to supporting the development and delivery of diagnostics for poverty-related diseases, announced today that Blue Frontier, a UK-based digital agency specializing in innovative healthcare solutions, is the recipient of the Connected Diagnostics Platform (CDP), following a request for proposals (RFP) and rigorous evaluation process.
CDP was conceptualized and developed by FIND in response to the increasing demand and need for device connectivity in low- and middle-income countries, where current management of medical records and surveillance data rely on paper-based methods or fragmented systems and databases.
The platform allows for centralized and secure aggregation, and flexible visualization and management, of clinical test and device performance data from diagnostics. It also provides the capability to digitize diagnostic test workflows and laboratory processes from patient registration, case history, examination and reporting of samples.
FIND brought CDP through the proof of concept phase, including successful testing and development and sought a commercial entity to bring CDP to market to sustain its development, seek new opportunities for the platform and guide its implementation. FIND has selected Blue Frontier to adopt CDP following an open RFP with an independent scoring process.
“CDP was created with the vision of catalysing action and diversification in diagnostic connectivity, an area of great need,” said Catharina Boehme, CEO of FIND. “We believe that Blue Frontier can continue to develop and enhance this core platform, strengthening the link from patient diagnosis to treatment and surveillance.”
As one of the nine priority digital health concepts identified by the WHO Agenda for Action on Digital health for the END TB Strategy for target product profiles, the adoption and use of diagnostics connectivity solutions are monitored as core indicators for laboratory strengthening. CDP has the potential to maximize public health impact, streamlining patient management, surveillance, quality assurance, laboratory operations, and technical product support.
FIND was established in 2003 as a global non-profit dedicated to accelerating the development, evaluation and delivery of high-quality, affordable diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, Ebola, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease and Buruli ulcer, and for fighting antimicrobial resistance and supporting outbreak preparedness. Over the last decade, FIND has partnered in the delivery of 20 new diagnostic tools and created an enabling environment for numerous others through the provision of specimen banks, reagent development and better market visibility. FIND also supports better access to new diagnostics through price negotiations, implementation, quality assurance and lab strengthening work. FIND has over 100 partners globally, including research institutes and laboratories, health ministries and national disease control programmes, commercial partners, bilateral and multilateral organizations, especially WHO, and clinical trial sites. Read more about FIND at www.finddx.org.
About Blue Frontier
Created in 2005, and based in the UK, Blue Frontier offers a full end-to-end digital service with an emphasis on knowledge, service and quality. Blue Frontier has provided software systems, mobile apps and database applications for healthcare organisations ranging from the NHS to some of the world’s leading diagnostic device manufactures.
Fully accredited to ISO standards 9001, 27001 & 13485, the Blue Frontier team offers design, development, integration, technical services and consultancy in application development. Blue Frontier’s expertise and passion for connecting diagnostic instruments and health data has led the company to play a central role in creating two of the world’s ground breaking connected health platforms. Blue Frontier’s understanding of the importance of capacity building and sustainability drives them to engage with colleagues and customers in the developing world to share knowledge, drive adoption and ensure that technology delivers benefit.